Back
Bioage Labs Vs. Perspective Therapeutics Industry Stock Comparison
Sell
41
BIOA
Bioage Labs
Last Price:
18.49
Seasonality Move:
--
Sell
30
CATX
Perspective Therapeutics
Last Price:
8.29
Seasonality Move:
28.97%
Sell
41
Bioage Labs (BIOA)
is a Sell
Is Bioage Labs a Buy, Sell or Hold?
- The current Bioage Labs [BIOA] share price is $19.51. The Score for BIOA is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
- BIOA is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
30
Perspective Therapeutics (CATX)
is a Sell
Is Perspective Therapeutics a Buy, Sell or Hold?
- The current Perspective Therapeutics [CATX] share price is $8.92. The Score for CATX is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
- CATX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
BIOA Stock Price Chart
What is Bioage Labs's stock price today?
-
The Bioage Labs share price today is $19.51
The current trend is relatively stagnant and BIOA is experiencing selling pressure, which indicates risk of future bearish movement.
CATX Stock Price Chart
What is Perspective Therapeutics's stock price today?
-
The Perspective Therapeutics share price today is $8.92
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CATX is experiencing selling pressure, which indicates risk of future bearish movement.
BIOA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.93 | Buy |
| Relative Strength Index (14 RSI): | 42.49 | Sell |
| Chaikin Money Flow: | -99811 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (21.18 - 24.56) | Sell |
| Bollinger Bands (100): | ( - ) | Buy |
CATX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.71 | Sell |
| Relative Strength Index (14 RSI): | 23.03 | Sell |
| Chaikin Money Flow: | -1324869 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (10.92 - 12.78) | Sell |
| Bollinger Bands (100): | (11.21 - 14.35) | Sell |
BIOA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 21.22 | Sell |
| 20-day SMA: | 22.84 | Sell |
| 50-day SMA: | 0 | Buy |
| 200-day SMA: | 0 | Buy |
| 8-day EMA: | 21.06 | Sell |
| 20-day EMA: | 21.29 | Sell |
| 50-day EMA: | 16.61 | Buy |
| 200-day EMA: | 6.45 | Buy |
CATX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 11.04 | Sell |
| 20-day SMA: | 11.63 | Sell |
| 50-day SMA: | 12.76 | Sell |
| 200-day SMA: | 12.8 | Sell |
| 8-day EMA: | 10.64 | Sell |
| 20-day EMA: | 11.47 | Sell |
| 50-day EMA: | 12.32 | Sell |
| 200-day EMA: | 11.71 | Sell |
Bioage Labs Earnings Growth & BIOA Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and an increase next year of $0.41 per share.
Perspective Therapeutics Earnings Growth & CATX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.77 per share, and a decrease next year of $0.25 per share.
Bioage Labs Technical Analysis
| Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Perspective Therapeutics Technical Analysis
| Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||